These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 28107415)

  • 21. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
    Moriyama T; Itabashi M; Takei T; Kataoka H; Sato M; Shimizu A; Iwabuchi Y; Nishida M; Uchida K; Nitta K
    J Nephrol; 2015 Aug; 28(4):451-6. PubMed ID: 25355499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperuricemia is associated with progression of IgA nephropathy.
    Bakan A; Oral A; Elcioglu OC; Takir M; Kostek O; Ozkok A; Basci S; Sumnu A; Ozturk S; Sipahioglu M; Turkmen A; Voroneanu L; Covic A; Kanbay M
    Int Urol Nephrol; 2015 Apr; 47(4):673-8. PubMed ID: 25761742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between uric acid levels and renal function of CKD patients with hyperlipidemia: a sub-analysis of the ASUCA trial.
    Kuwabara Y; Yasuno S; Kasahara M; Ueshima K; Nakao K
    Clin Exp Nephrol; 2020 May; 24(5):420-426. PubMed ID: 31875936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
    Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
    Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urate Transporter ABCG2 Function and Asymptomatic Hyperuricemia: A Retrospective Cohort Study of CKD Progression.
    Ohashi Y; Kuriyama S; Nakano T; Sekine M; Toyoda Y; Nakayama A; Takada T; Kawamura Y; Nakamura T; Matsuo H; Yokoo T; Ichida K
    Am J Kidney Dis; 2023 Feb; 81(2):134-144.e1. PubMed ID: 35810827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of changes in serum uric acid levels on renal function in elderly patients with hypertension: a retrospective cohort study with 3.5-year follow-up.
    Lin F; Zhang H; Huang F; Chen H; Lin C; Zhu P
    BMC Geriatr; 2016 Feb; 16():35. PubMed ID: 26842652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
    See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
    J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperuricemia associated with rapid renal function decline in elderly Taiwanese subjects.
    Yen CJ; Chiang CK; Ho LC; Hsu SH; Hung KY; Wu KD; Tsai TJ
    J Formos Med Assoc; 2009 Dec; 108(12):921-8. PubMed ID: 20040456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urate-lowering agents for asymptomatic hyperuricemia in stage 3 - 4 chronic kidney disease: Controversial role of kidney function.
    Jeon HJ; Oh J; Shin DH
    PLoS One; 2019; 14(6):e0218510. PubMed ID: 31206563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis.
    Momoki K; Kataoka H; Moriyama T; Mochizuki T; Nitta K
    J Atheroscler Thromb; 2017 Jun; 24(6):630-642. PubMed ID: 27784849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Urate Lowering Therapy on Renal Disease Progression in Hyperuricemic Patients with Chronic Kidney Disease.
    Kim Y; Shin S; Kim K; Choi S; Lee K
    J Rheumatol; 2015 Nov; 42(11):2143-8. PubMed ID: 26428209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of dotinurad in patients with severe renal dysfunction.
    Kurihara O; Yamada T; Kato K; Miyauchi Y
    Clin Exp Nephrol; 2024 Mar; 28(3):208-216. PubMed ID: 37864678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergetic Association between Anemia and Hyperuricemia on New-Onset Chronic Kidney Disease in a Large Taiwanese Population Follow-Up Study.
    Chen YC; Liu YH; Wu PY; Huang JC; Su HM; Chen SC; Chang JM
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperuricemia after orthotopic liver transplantation: divergent associations with progression of renal disease, incident end-stage renal disease, and mortality.
    Longenecker JC; Waheed S; Bandak G; Murakami CA; McMahon BA; Gelber AC; Atta MG
    BMC Nephrol; 2017 Mar; 18(1):103. PubMed ID: 28347282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum uric acid and the incidence of CKD and hypertension.
    Kuriyama S; Maruyama Y; Nishio S; Takahashi Y; Kidoguchi S; Kobayashi C; Takahashi D; Sugano N; Hosoya T; Yokoo T
    Clin Exp Nephrol; 2015 Dec; 19(6):1127-34. PubMed ID: 25967597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.
    Zoppini G; Targher G; Chonchol M; Ortalda V; Abaterusso C; Pichiri I; Negri C; Bonora E
    Diabetes Care; 2012 Jan; 35(1):99-104. PubMed ID: 22028277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
    Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV
    Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between uric acid levels and risk of chronic kidney disease in a retrospective cohort of Brazilian workers.
    Chini LSN; Assis LIS; Lugon JR
    Braz J Med Biol Res; 2017 Aug; 50(9):e6048. PubMed ID: 28793050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community-based population.
    Kamei K; Konta T; Hirayama A; Suzuki K; Ichikawa K; Fujimoto S; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Kimura K; Narita I; Kondo M; Asahi K; Watanabe T
    Nephrol Dial Transplant; 2014 Dec; 29(12):2286-92. PubMed ID: 25061123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral uricase eliminates blood uric acid in the hyperuricemic pig model.
    Szczurek P; Mosiichuk N; Woliński J; Yatsenko T; Grujic D; Lozinska L; Pieszka M; Święch E; Pierzynowski SG; Goncharova K
    PLoS One; 2017; 12(6):e0179195. PubMed ID: 28594873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.